That might be true and I'm sure after many years dealing with govts they should have learned their lesson not to overcook forecasts. Taking this principle then delays from 2020 will spill over into 2021 and so on.
It's about framing it correctly. In any case if revenue is 25m, why not forecast 20-25m and be conservative. The share price wouldn't tank in fact it would be higher as the market perceives the company as growing even quicker than mgmt expects it to.
- Forums
- ASX - By Stock
- Ann: Business Update
That might be true and I'm sure after many years dealing with...
-
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PET (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online